Copyright
©2005 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2005; 11(2): 255-259
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.255
Published online Jan 14, 2005. doi: 10.3748/wjg.v11.i2.255
Table 3 Comparison between NAFLD patients with stage 0-2 fibrosis and those with stage 3 and 4 fibrosis (mean±SD).
Stages 0-2 fibrosis | Stages 3,4 fibrosis | P value | |
Number | 64 | 48 | |
Age (yr) | 47.8±14.5 | 54.3±14.0 | 0.02 |
Gender (female) | 38 (59.4%) | 38 (79.2%) | 0.04 |
BMI | 28.3±4.8 | 30.1±5.4 | NS |
Diabetes mellitus (%) | 15 (23.4%) | 19 (39.6%) | NS |
Platelet count (±104/mL) | 23.8±5.1 | 20.3±7.1 | 0.004 |
Prothrombin time (%) | 96.9±11.1 | 90.1±14.7 | 0.018 |
Albumin (g/dL) | 4.4±0.3 | 4.3±0.4 | 0.03 |
AST (IU/L) | 67.0±37.5 | 87.9±51.2 | 0.02 |
ALT (IU/L) | 113.1±65.2 | 116.3±67.9 | NS |
AST/ALT ratio | 0.66±0.4 | 0.82±0.3 | 0.015 |
GGT (IU/L) | 133.5±141.6 | 85.7±66.6 | 0.019 |
IgG (mg/dL) | 1 408.1±367.0 | 1 555.5±446.4 | NS |
IgA (mg/dL) | 316.3±172.3 | 371.0±133.5 | NS |
IgM (mg/dL) | 137.2±79.1 | 163.8±64.9 | NS |
Type IV collagen 7S (ng/mL) | 4.6±1.5 | 6.3±2.0 | <0.001 |
Hyaluronic acid (ng/mL) | 50.4±74.3 | 108.8±118.7 | 0.004 |
Fasting glucose (mg/dL) | 115.1±49.4 | 116.6±43.1 | NS |
HbA1c (%) | 5.6±1.2 | 6.4±1.9 | 0.01 |
Ferritin (ng/mL) | 253.8±52.6 | 320.1±373.0 | NS |
FFA (mEq/L) | 0.6±0.3 | 0.8±0.3 | 0.007 |
HOMA-R | 5.7±5.8 | 5.8±4.6 | NS |
- Citation: Sakugawa H, Nakayoshi T, Kobashigawa K, Yamashiro T, Maeshiro T, Miyagi S, Shiroma J, Toyama A, Nakayoshi T, Kinjo F, Saito A. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol 2005; 11(2): 255-259
- URL: https://www.wjgnet.com/1007-9327/full/v11/i2/255.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i2.255